Scholars Central

Conference abstractPublished 16 May 2022

An open clinical evaluation of selected siddha regimen in expediting the management of covid-19 - a randomized controlled study

Authors: S.M. Chitra

Government Siddha Medical College, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: The corona virus disease 2019 (COVID-19), an acute respiratory disease, caused by a novel corona virus (SARS-CoV-2, previously known as 2019-nCoV), obtained worldwide attention. The World Health Organization (WHO) officially declared the Covid-19 epidemic as a public health emergency of international concern. In this review, we explored the potential siddha strategies for covid – 19 infections. Aim and objectives: To evaluate the additional benefits of siddha drugs Vasantha kusumakaram mathirai, Thippili rasayanam, Adathodai manapagu and Kabasura kudineer compared to the allopathic standard treatment alone in COVID-19 asymptomatic, mild – moderate cases. Materials and Methods: The present study was an open label Two arm - randomized controlled interventional clinical study. Group I patients were assigned to Siddha add on treatment whereas Group II patients were assigned to standard treatment alone. The patients recruited for the study were Covid 19 RT-PCR +ve patients declared by Tamil Nadu Government and admitted in IPD (in patient ward) at Omandurar Government Medical College Hospital. The sample size was 100 for each group. Result: Among the gender distribution observed in Siddha add on Group and standard Group 71, 69 were males and 29, 31 were females respectively. The mean age of patients was observed as 42.98 in Siddha add on Group and 45.68 in standard Group. The average number of days taken for reduction of symptoms after the treatment was 3.21 in Siddha add on Group and 5.13 in standard Group (n=100) and the Siddha add on Group showed significant results (P<0.001) when compared with standard Group. The real – time polymerase chain reaction (RT-PCR) investigation turned negative for 78.33% in Siddha add on Group and 33.33% in standard Group patients after 11-14 days duration of treatment. Similarly, the before and after Computed tomography (CT) chest, Ground glass opacities covid pattern lung involvement percentage showed highly significant reduction (P<0.0001) in Siddha add on Group, when compared with standard Group, which showed significant reduction (P<0.001) for the same. In addition, Neutrophil Lymphocyte Ratio (NLR) ratio, showed significant reduction (P<0.01) when analyzed by Wilcoxon signed rank test in Siddha add on Group. Renal and Liver parameter test were carried out for 25 patients in Siddha add on Group as posttest. They were observed within the normal limits. Conclusion: Finally, it was concluded that Siddha add on treatment Group showed accelerated recovery for Covid - 19 patients compared to standard treatment Group. The synergistic effect of Siddha add on with standard treatment gave more promising results in the current study of Covid -19.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Alternative & Integrative Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAlternative & Integrative Medicine
  • SubjectAlternative & Palliative Care
  • BylineArticles whose byline prints “S.M. Chitra”